Overview
Peficitinib has been used in trials studying the treatment and basic science of Psoriasis, Pharmacodynamics, Drug Interactions, Colitis, Ulcerative, and RHEUMATOID ARTHRITIS, among others.
Indication
用于治疗对常规疗法反应不足的类风湿性关节炎（包括预防结构性关节损伤）患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2019/10/29 | Phase 1 | Completed | |||
2019/06/03 | N/A | Recruiting | |||
2018/09/06 | Phase 3 | Completed | |||
2016/05/03 | Phase 1 | Completed | |||
2015/08/24 | Phase 1 | Completed | |||
2014/12/04 | Phase 3 | Completed | |||
2014/12/03 | Phase 3 | Completed | |||
2012/12/21 | Phase 1 | Completed | |||
2012/10/22 | Phase 2 | Completed | |||
2012/07/25 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Peficitinib Hydrobromide Tablets | 国药准字HJ20240076 | 化学药品 | 片剂 | 7/30/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.